Skip to content

ADMA Biologics ADMA Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$45.33M-8.2%$49.38M+35.6%$36.43M+6.5%$34.22M+27.2%$26.9M-76.0%
$1.8M-10.0%$2M0.0%$2M0.0%$2M+5.3%$1.9M-5.0%
$6.33M+17.4%$5.39M+6.8%$5.05M+1.7%$4.96M+7.3%$4.62M-14.9%
$58.25M+63.4%$35.64M+168%$13.29M-37.1%$21.14M+207%-$19.68M-139%
$2.54M+135%$1.08M-92.5%$14.37M+493%$2.42M-48.5%$4.7M+70.5%
$2.4M+971%-$276K+98.1%-$14.37M-469%-$2.53M+46.5%-$4.72M-71.6%
$130.19M+1,362%$8.9M$0
-$10.13M-11.1%-$9.12M+67.2%-$27.83M$0+100%-$7.13M+77.0%
$50.52M-$28.9M-$31.52M-292%
$55.71M+61.2%$34.56M+3,314%-$1.08M-106%$18.72M+177%-$24.38M-151%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does ADMA Biologics generate?
ADMA Biologics (ADMA) generated $128.3M in operating cash flow over the trailing twelve months.
What is ADMA Biologics's free cash flow?
After $20.4M of capital expenditures, ADMA Biologics's free cash flow was $107.9M over the trailing twelve months, up 19.1% year over year.
Where does ADMA Biologics's cash flow data come from?
Every line is extracted from ADMA Biologics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.